IP Library › Granted Patent US 10,816,538
Granted Patent B2
US 10,816,538 · App. 16/072,423 · Granted Oct 27, 2020

Methods and apparatus for detecting an interferent in a specimen

Inventors: Stefan Kluckner (Berlin, DE); Yao-Jen Chang (Princeton, NJ); Terrence Chen (Princeton, NJ); Benjamin S. Pollack (Jersey City, NJ); Patrick Wissmann (Munich, DE)
Assignee: Siemens Healthcare Diagnostics Inc.
G01N33/491G01N21/251G01N21/31G01N21/314G01N33/492G06T7/0012G01N2201/1293G06T2207/10024G06T2207/10048G06T2207/20076G06T2207/20081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,816,538
App. No.
16/072,423
Granted
Oct 27, 2020
Kind
B2
Abstract

A model-based method of inspecting a specimen for presence of an interferent (H, I, and/or L). The method includes capturing images of the specimen at multiple different exposures times and at multiple spectra having different nominal wavelengths, selection of optimally-exposed pixels from the captured images to generate optimally-exposed image data for each spectra, identifying a serum or plasma portion of the specimen, and classifying whether an interferent is present or absent within the serum or plasma portion. Testing apparatus and quality check modules adapted to carry out the method are described, as are other aspects.

Claims (48)

1. A method of determining an interferent in a specimen contained within a specimen container, comprising:

providing a specimen contained in a specimen container;

providing two or more cameras;

with each camera, capturing images of the specimen at varying exposure times and at multiple different spectra having different nominal wavelengths;

selection of optimally-exposed pixels from the images at the varying exposure times at each of the spectra to generate optimally-exposed image data for each spectra;

classifying a serum or plasma portion of the specimen; and

determining whether an interferent is:

present within the serum or plasma portion, or

absent within the serum or plasma portion.

2. The method of claim 1 , wherein the classifying the serum or plasma portion includes computing statistics of the optimally-exposed pixels at the different spectra to generate statistical data.

3. The method of claim 1 , wherein the specimen is a centrifuged specimen including a separated blood portion and the serum or plasma portion.

4. The method of claim 1 , wherein the capturing images of the specimen involves capturing multiple images with cameras from a number of different viewpoints.

5. The method of claim 4 , wherein the number of viewpoints comprises 3 or more.

6. The method of claim 1 , wherein the multiple different spectra comprise two or more spectra between about 400 nm and about 1500 nm.

7. The method of claim 1 , wherein the multiple different spectra comprise two or more spectra between about 400 nm and about 700 nm.

8. The method of claim 1 , wherein the multiple different spectra comprise red light, green light, blue light.

9. The method of claim 1 , wherein the multiple different spectra comprise infrared and near infrared light.

10. The method of claim 1 , wherein the varying exposure times comprise between about 0.1 ms and about 256 ms.

11. The method of claim 1 , wherein the selection of optimally-exposed pixels comprises selection of pixels from the images that include intensities between 16-254 based upon a range of 0-255.

12. The method of claim 1 , wherein the classifying the serum or plasma portion comprises using a multi-class classifier.

13. The method of claim 12 , wherein the multi-class classifier comprises a support vector machine or a random decision tree.

14. The method of claim 1 , wherein the determining a presence or absence of an interferent in the serum or plasma portion is based upon an interferent classifier generated from multiple training sets.

15. The method of claim 14 , wherein the interferent classifier comprises a multi-class classifier capable of discerning hemolysis, icterus, and lipemia.

16. The method of claim 14 , wherein the interferent classifier comprises individual binary classifiers capable of individually discerning hemolysis, icterus, and lipemia.

17. The method of claim 1 , wherein selection of optimally-exposed pixels further comprises selecting a pixel having the highest intensity in response to more than one pixel being determined as optimally-exposed.

18. A quality check module adapted to determine presence of an interferent in a specimen contained within a specimen container, comprising:

a plurality of cameras arranged around the specimen container and configured to capture multiple images of the specimen at varying exposure times and multiple spectra having different nominal wavelengths and from multiple viewpoints; and

a computer coupled to the plurality of cameras and adapted to process image data of the multiple images, the computer configured to:

select optimally-exposed pixels from the multiple images at the varying exposure times for each spectra and generate optimally-exposed image data for each spectra,

classify a serum or plasma portion of the specimen, and

classify whether an interferent is:

present within the serum or plasma portion, or

absent within the serum or plasma portion.

19. The quality check module of claim 18 comprising a housing surrounding the specimen container received in a carrier, the carrier provided on a track.

20. The quality check module of claim 19 comprising an opening in a ceiling of the housing configured to allow specimen containers to be loaded into the quality check module from a top.

21. The quality check module of claim 18 comprising a plurality of RGB light sources providing back lighting.

22. The quality check module of claim 18 comprising a plurality of white light sources providing front lighting.

23. The quality check module of claim 18 , wherein the computer is further configured and capable of being operated to select optimally-exposed pixels from the multiple images at the varying exposure times for each spectra and generate optimally-exposed image data for each spectra, wherein the optimally-exposed pixels comprise pixels greater than a minimum intensity and less a maximum intensity.

24. A specimen testing apparatus adapted to determine presence of an interferent in a specimen contained within a specimen container, comprising:

a track;

a carrier moveable on the track and configured to contain the specimen container;

a plurality of cameras arranged around the track and configured to capture multiple images of the specimen at varying exposure times and multiple spectra including different nominal wavelengths and from multiple viewpoints; and

a computer coupled to the plurality of cameras and configured to process image data from the multiple images, the computer configured to:

select optimally-exposed pixels from the multiple images at the varying exposure times and spectra to generate optimally-exposed image data for each spectra,

classify a serum or plasma portion of the specimen, and

classify whether an interferent is

present within the serum or plasma portion, or

absent within the serum or plasma portion.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: WISSMANN, PATRICK
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 049437/0848 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: SIEMENS AKTIENGESELLSCHAFT
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 049437/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: KLUCKNER, STEFAN; CHANG, YAO-JEN; CHEN, TERRENCE
To: SIEMENS CORPORATION
Reel/Frame 049437/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: SIEMENS CORPORATION
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 049437/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: POLLACK, BENJAMIN S.
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 049438/0047 →
Continuity (2)
Provisional Application 62288375 · Jan 28, 2016
Related Publication 20180372715A1 · Dec 27, 2018
Cited By (2)
US 12,287,327 US 12,596,132